200 related articles for article (PubMed ID: 26662399)
1. Detection of serum anti-melanocyte antibodies and identification of related antigens in patients with vitiligo.
Zhu MC; Liu CG; Wang DX; Zhan Z
Genet Mol Res; 2015 Dec; 14(4):16060-73. PubMed ID: 26662399
[TBL] [Abstract][Full Text] [Related]
2. Hydroxychloroquine protects melanocytes from autoantibody-induced injury by reducing the binding of antigen-antibody complexes.
Li DG; Hu WZ; Ma HJ; Liu W; Yang QQ; Zhao G
Mol Med Rep; 2016 Aug; 14(2):1275-82. PubMed ID: 27277530
[TBL] [Abstract][Full Text] [Related]
3. Apoptosis of melanocytes in vitiligo results from antibody penetration.
Ruiz-Argüelles A; Brito GJ; Reyes-Izquierdo P; Pérez-Romano B; Sánchez-Sosa S
J Autoimmun; 2007 Dec; 29(4):281-6. PubMed ID: 17888626
[TBL] [Abstract][Full Text] [Related]
4. Smyth chicken melanocyte autoantibodies: cross-species recognition, in vivo binding, and plasma membrane reactivity of the antiserum.
Searle EA; Austin LM; Boissy YL; Zhao H; Nordlund JJ; Boissy RE
Pigment Cell Res; 1993 Jun; 6(3):145-57. PubMed ID: 8234200
[TBL] [Abstract][Full Text] [Related]
5. [Detection of serum autoantibodies to melanocyte and correlation between melanoma antigen recognized by T-cells and vitiligo in children].
Chen JP; Li HP; Jin SH; Zhang JT; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Oct; 29(10):2107-8, 2111. PubMed ID: 19861278
[TBL] [Abstract][Full Text] [Related]
6. Identification of autoantibody to melanocytes and characterization of vitiligo antigen in vitiligo patients.
Park YK; Kim NS; Hann SK; Im S
J Dermatol Sci; 1996 Feb; 11(2):111-20. PubMed ID: 8869031
[TBL] [Abstract][Full Text] [Related]
7. Vitiligo autoantigen VIT75 is identified as lamin A in vitiligo by serological proteome analysis based on mass spectrometry.
Li Q; Lv Y; Li C; Yi X; Long HA; Qiao H; Lu T; Luan Q; Li K; Wang X; Wang G; Gao T
J Invest Dermatol; 2011 Mar; 131(3):727-34. PubMed ID: 21085190
[TBL] [Abstract][Full Text] [Related]
8. Mammalian tyrosinase-related protein-1 is recognized by autoantibodies from vitiliginous Smyth chickens. An avian model for human vitiligo.
Austin LM; Boissy RE
Am J Pathol; 1995 Jun; 146(6):1529-41. PubMed ID: 7778691
[TBL] [Abstract][Full Text] [Related]
9. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo.
Kroon MW; Kemp EH; Wind BS; Krebbers G; Bos JD; Gawkrodger DJ; Wolkerstorfer A; van der Veen JP; Luiten RM
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1172-5. PubMed ID: 22404127
[TBL] [Abstract][Full Text] [Related]
10. IgG anti-melanocyte antibodies purified from patients with active vitiligo induce HLA-DR and intercellular adhesion molecule-1 expression and an increase in interleukin-8 release by melanocytes.
Li YL; Yu CL; Yu HS
J Invest Dermatol; 2000 Dec; 115(6):969-73. PubMed ID: 11121127
[TBL] [Abstract][Full Text] [Related]
11. HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1.
Lang KS; Caroli CC; Muhm A; Wernet D; Moris A; Schittek B; Knauss-Scherwitz E; Stevanovic S; Rammensee HG; Garbe C
J Invest Dermatol; 2001 Jun; 116(6):891-7. PubMed ID: 11407977
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to human melanocyte-specific protein pmel17 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1998 Dec; 114(3):333-8. PubMed ID: 9844040
[TBL] [Abstract][Full Text] [Related]
13. Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2).
Kemp EH; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 1997 Sep; 109(3):495-500. PubMed ID: 9328128
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
[TBL] [Abstract][Full Text] [Related]
15. Molecular mapping of epitopes on melanocyte-specific protein Pmel17 which are recognized by autoantibodies in patients with vitiligo.
Kemp EH; Waterman EA; Gawkrodger DJ; Watson PF; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):509-15. PubMed ID: 11472416
[TBL] [Abstract][Full Text] [Related]
16. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo.
Kemp EH; Waterman EA; Hawes BE; O'Neill K; Gottumukkala RV; Gawkrodger DJ; Weetman AP; Watson PF
J Clin Invest; 2002 Apr; 109(7):923-30. PubMed ID: 11927619
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinase as an autoantigen in patients with vitiligo.
Baharav E; Merimski O; Shoenfeld Y; Zigelman R; Gilbrud B; Yecheskel G; Youinou P; Fishman P
Clin Exp Immunol; 1996 Jul; 105(1):84-8. PubMed ID: 8697641
[TBL] [Abstract][Full Text] [Related]
18. Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
Okamoto T; Irie RF; Fujii S; Huang SK; Nizze AJ; Morton DL; Hoon DS
J Invest Dermatol; 1998 Dec; 111(6):1034-9. PubMed ID: 9856813
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of antigens reacting with vitiligo and cytoplasmic melanoma antibodies].
Presser HJ; Morenz J; Höfs T; Zugehör M; Kühne KH; Brödemann M
Dermatol Monatsschr; 1987; 173(8):441-5. PubMed ID: 3311840
[No Abstract] [Full Text] [Related]
20. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo.
Fishman P; Merimski O; Baharav E; Shoenfeld Y
Cancer; 1997 Apr; 79(8):1461-4. PubMed ID: 9118024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
